Directory of Therapeutics » Therapeutics News
Latest global therapeutics news story headlines. Therapeutics, medicine, pharmaceutical and alternative therapy news stories from around the world.
ProactiveLife launches new Diabetes Support supplement
ProactiveLife, a provider of natural supplements, has launched new Diabetes Support supplement for people with Type 2 Diabetes and Pre-Diabetes.
OphthaliX receives Chinese patent for treatment of dry eye disorders
OphthaliX has received patent, entitled Adenosine A3 receptor agonists for the treatment of dry eye disorders, from Chinese State Intellectual Property Office (SIPO).
Enzo Biochem wins approval for ColonSentry RNA expression assay
Enzo Biochem has received New York State Department of Health approval for ColonSentry RNA expression assay to assess colorectal cancer risk.
Study detects C-peptide production in diabetes patients decades after disease onset
Researchers at Massachusetts General Hospital (MGH) have identified insulin production in type 1 diabetes patients decades after disease onset.
FDA grants orphan-drug designation to Arno CNS drug
FDA has granted orphan-drug designation to Arno Therapeutics' investigational compound, AR-42, for the treatment of meningioma and schwannoma of the central nervous system.
ProactiveLife, a provider of natural supplements, has launched new Diabetes Support supplement for people with Type 2 Diabetes and Pre-Diabetes.
OphthaliX receives Chinese patent for treatment of dry eye disorders
OphthaliX has received patent, entitled Adenosine A3 receptor agonists for the treatment of dry eye disorders, from Chinese State Intellectual Property Office (SIPO).
Enzo Biochem wins approval for ColonSentry RNA expression assay
Enzo Biochem has received New York State Department of Health approval for ColonSentry RNA expression assay to assess colorectal cancer risk.
Study detects C-peptide production in diabetes patients decades after disease onset
Researchers at Massachusetts General Hospital (MGH) have identified insulin production in type 1 diabetes patients decades after disease onset.
FDA grants orphan-drug designation to Arno CNS drug
FDA has granted orphan-drug designation to Arno Therapeutics' investigational compound, AR-42, for the treatment of meningioma and schwannoma of the central nervous system.
